CardioVision™
Due to its unique Features, CardioVision™ can both evaluate the Heart Function and visualize the anatomical Location and Size of Infarct.
Since the Amount of Myocardial Damage and the Degree of Loss of Heart function are strong predictors of future Cardiac Events, CardioVision™ has prognostic value in the assessment of the Degree of Myocardial Damage in the Management of Patients with Acute Coronary Syndrome.
In connection with future Applications such as Stem Cell Therapy, CardioVision™ will be of inestimable Value to localise the Place of the Injection.
In order to keep Stem Cell Therapy available, CardioVision™ must be used within the 6 Days window following the Onset of the Myocardial Infarction.
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||||
 |
|
||||||||